Clinical Trial

CD8 PET Imaging in Metastatic Solid Tumours

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a multi-center, single-arm trial designed to evaluate the safety and imaging characteristics of 89Zr-Df-crefmirlimab in patients with locally advanced or metastatic solid tumours prior to and during PD-1 antibody therapy.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-07-29; most recent amendment 2026-02-05.
Status change: Not Yet Recruiting → Recruiting 2025-03-28
Trial Details
NCT Number NCT06534190
Lead Sponsor University Medical Center Groningen
Conditions Locally Advanced Solid Tumor
Enrollment 30 participants
Start Date 2025-03-11
Primary Completion 2028-11 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-02-09